AXA Framlington Biotech R Income GBP/ GB0031007148 /
| NAV01/11/2024 | Chg.-0.0330 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2.7390GBP | -1.19% | paying dividend | Equity | AXA IM (UK) ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 03/11/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 14/06/2024 | Prospectus | 2024 | English | 1,408.52 KB |
| 01/06/2024 | Key Investor Information | 2024 | English | 74.14 KB |
| 29/02/2024 | Semi-annual report | 2024 | English | 526.65 KB |
| 31/08/2023 | Account statment | 2023 | English | 594.13 KB |
